Effectiveness and tolerability of perampanel in children and adolescents with refractory epilepsies: first experiences

Neuropediatrics
Anna BiróGerhard Kluger

Abstract

This article aims to report the first clinical experiences concerning effectiveness and tolerability of perampanel (PER) in a pediatric population with refractory epilepsies. This nonsponsored, observational, retrospective survey was conducted through collaboration with multiple centers in Europe. The clinical course of the first pediatric patients treated in these centers with PER was documented with the help of a questionnaire completed by the treating physicians. Effectiveness and adverse effects were evaluated. The study population consisted of 58 patients (mean age, 10.5 years; range, 2-17 years), suffering from various refractory epilepsies, classified as focal epilepsy (n = 36), unclassified generalized epilepsy (n = 12), Lennox-Gastaut syndrome (n = 5), West syndrome (n = 3), and Dravet syndrome (n = 2). The response rate (≥ 50% seizure reduction) after the first 3 months of therapy was 31% (18/58 patients) in total. Complete seizure control was achieved in five patients (9% overall). Aggravation of seizures occurred in five cases (9%). The most frequently occurring adverse effects were reduced vigilance or fatigue (n = 16) and behavioral changes (n = 14). PER seems to be effective also in children and adolescents with ...Continue Reading

Citations

Oct 6, 2015·Expert Review of Clinical Pharmacology·Adam StrzelczykSebastian Bauer
May 8, 2016·Current Treatment Options in Neurology·Katharina Vezyroglou, J Helen Cross
Jun 4, 2016·Pharmacological Reviews·Martin J BrodieBernhard J Steinhoff
Jun 9, 2016·Der Nervenarzt·M HintzA Schulze-Bonhage
Jun 9, 2016·Expert Opinion on Pharmacotherapy·Alexandra RohracherEugen Trinka
Oct 1, 2016·Brain and Behavior·Heung Dong KimAmitabh Dash
Dec 10, 2016·Developmental Medicine and Child Neurology·Eli HeymanRevital Gandelman-Marton
Jun 3, 2016·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Leslie A RudzinskiIoannis Karakis
Jan 28, 2017·Developmental Medicine and Child Neurology·Guido Rubboli
May 18, 2017·Journal of Child Neurology·Anita N DattaMary B Connolly
Dec 8, 2017·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·V I GuzevaN E Maksimova
Jun 29, 2018·Epilepsia·Heidrun Potschka, Eugen Trinka
Sep 1, 2018·Expert Opinion on Drug Safety·Romina MoaveroPaolo Curatolo
Jan 29, 2019·Expert Opinion on Drug Metabolism & Toxicology·Alberto VerrottiMaria Laura Iezzi
Mar 12, 2019·Korean journal of pediatrics·Jon Soo Kim, Won Seop Kim
Oct 27, 2017·Clinical Drug Investigation·Alberto VerrottiPaolo Curatolo
Jul 5, 2018·Journal of Clinical Neurology·Song Ee YounHeung Dong Kim
Jul 14, 2018·Paediatric Drugs·Giulia IapadreAlberto Verrotti
Feb 28, 2019·Journal of Epilepsy Research·Soo Yeon KimKi Joong Kim
Jun 5, 2017·Italian Journal of Pediatrics·Paola De LisoAlberto Verrotti
Sep 16, 2015·Drugs·James E Frampton
Jan 23, 2021·CNS Drugs·Adam Strzelczyk, Susanne Schubert-Bast
Dec 27, 2019·Seizure : the Journal of the British Epilepsy Association·Arielle CrespelPierre Genton
Feb 2, 2021·Frontiers in Neurology·Celina von StülpnagelUNKNOWN NETRE Consortium
Dec 5, 2020·Brain & Development·Bernadette MacrohonBenilda Sanchez-Gan
Jun 1, 2021·Epilepsy & Behavior : E&B·Chusak Limotai, Suda Jirasakuldej

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.